<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0620">
 <label>124</label>
 <element-citation publication-type="journal" id="sbref0620">
  <person-group person-group-type="author">
   <name>
    <surname>Cong</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Hart</surname>
    <given-names>B.J.</given-names>
   </name>
   <name>
    <surname>Gross</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Frieman</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Bollinger</surname>
    <given-names>L.</given-names>
   </name>
  </person-group>
  <article-title>MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells</article-title>
  <source>PLoS One</source>
  <volume>13</volume>
  <year>2018</year>
  <object-id pub-id-type="publisher-id">e019486</object-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0194868</pub-id>
 </element-citation>
</ref>
